IDH1 and central nervous system cancer: In our study, we identified a unique subtype of gliomas based on the expression of ARLs, in which cluster 1 was associated with poor prognosis and enriched with the malignant subtype of gliomas including IDH1 wildtype, 1p19q non-codeleted, and MGMT unmethylated ones.